...
首页> 外文期刊>Seminars in Thrombosis and Hemostasis >Intracranial Hemorrhage: A Devastating Outcome of Congenital Bleeding DisordersPrevalence, Diagnosis, and Management, with a Special Focus on Congenital Factor XIII Deficiency
【24h】

Intracranial Hemorrhage: A Devastating Outcome of Congenital Bleeding DisordersPrevalence, Diagnosis, and Management, with a Special Focus on Congenital Factor XIII Deficiency

机译:颅内出血:先天性出血紊乱,诊断和管理的毁灭性结果,特别关注先天性因素XIII缺乏

获取原文
获取原文并翻译 | 示例
           

摘要

Intracranial hemorrhage (ICH) is a medical emergency. In congenital bleeding disorders, ICH is a devastating presentation accompanied with a high rate of morbidity and mortality. The prevalence of ICH is highly variable among congenital bleeding disorders, with the highest incidence observed in factor (F) XIII deficiency (FXIIID) (approximate to 30%). This life-threatening presentation is less common in afibrinogenemia, FVIII, FIX, FVII, and FX deficiencies, and is rare in severe FV and FII deficiencies, type 3 von Willebrand disease and inherited platelet function disorders (IPFDs). In FXIIID, this diathesis most often occurs after trauma in children, whereas spontaneous ICH is more frequent in adults. About 15% of patients with FXIIID and ICH die; the bleeding causes 80% of deaths in this coagulopathy. Although in FXIIID, the bleed most commonly is intraparenchymal ( 90%), epidural, subdural, and subarachnoid hemorrhages also have been reported, albeit rarely. As this life-threatening bleeding causes neurological complications, early diagnosis can prevent further expansion of the hematoma and secondary damage. Neuroimaging plays a crucial role in the diagnosis of ICH, but signs and symptoms in patients with severe FXIIID should trigger replacement therapy even before establishment of the diagnosis. Although a high dose of FXIII concentrate can reduce the rate of morbidity and mortality of ICH in FXIIID, it may occasionally trigger inhibitor development, thus complicating ICH management and future prophylaxis. Nevertheless, replacement therapy is the mainstay of treatment for ICH in FXIIID. Neurosurgery is performed in patients with FXIIID and epidural hematoma and a hemorrhage diameter exceeding 2 cm or a volume of ICH is more than 30 cm (3) . Contact sports are not recommended in people with FXIIID as they can elicit ICH. However, a considerable number of safe sports and activities have been suggested to have more benefits than dangers for patients with congenital bleeding disorders, and are hence suitable for these patients.
机译:颅内出血(ICH)是医疗紧急情况。在先天性出血障碍中,ICH是一种毁灭性的演示,伴随着高度的发病率和死亡率。先天性出血障碍中,ICH的患病率是高度可变的,因子(F)XIII缺乏(FXIIID)中观察到的最高发病率(近似为30%)。这种危及生命的介绍在血统血症,FVIII,FIX,FVII和FX缺陷中的常见不太常见,并且在严重的FV和FII缺陷中罕见,3型von Willebrand疾病和继承的血小板功能障碍(IPFDS)。在FxIIID中,这种蛋白质最常发生在儿童的创伤后发生,而自发性ICH在成年人中更频繁。大约15%的患者患有FxIIID和ICH死亡;出血会导致这种凝血病的80%死亡。虽然在FxIIID中,最常出血是颅内(& 90%),硬膜外,硬囊和蛛网膜下腔出血,也很少报告。由于这种危及生命的出血导致神经系统并发症,早期诊断可以防止血肿和二次损害的进一步扩张。神经影像在诊断中起着至关重要的作用,但严重的FxIIID患者的症状和症状应该在建立诊断之前引发替代疗法。虽然高剂量的FXIII浓缩物可以降低FXIIID中的发病率和死亡率,但它可能偶尔引发抑制剂的发育,从而使ICH管理和未来预防复杂化。然而,替代疗法是FxIIID中ICH治疗的主要疗法。神经外科在患有FxIIID和硬膜外血肿的患者中进行,出血直径超过2cm或体积的ICH大于30cm(3)。由于他们可以引发Ich,不推荐与FXIIID的人们联系运动。然而,已经提出了相当数量的安全体育和活动,这些活动比先天性出血障碍患者的危险更具益处,因此适合这些患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号